Clinical Trial Update: Proton Pump Inhibitors and Risk of Community-acquired Pneumonia

View source ↗

Summary

Clinical trial update assessing whether proton pump inhibitors are associated with an increased risk of community-acquired pneumonia in patients with gastroesop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia
• Gastroesophageal Reflux Disease

Snippet

Sponsor: Canadian Network for Observational Drug Effect Studies, CNODES | Conditions: Gastroesophageal Reflux Disease (GERD), Community-acquired Pneumonia | Status: COMPLETED